Related Experiment Videos
Invasive Haemophilus influenzae type B infections: a continuing challenge
H Janai1, H R Stutman, M I Marks
1Memorial Miller Children's Hospital, Long Beach, CA 90801-1428.
Insights
Invasive Haemophilus influenzae type b infections cause severe illness in young children. New vaccine strategies are crucial for preventing these infections and reducing child mortality.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Invasive Haemophilus influenzae type b infections are a significant cause of severe illness in children aged 2 months to 5 years.
- These infections, including meningitis and pneumonia, affect approximately 25,000 children annually, leading to substantial mortality and morbidity.
- Despite available potent antibiotics, mortality and morbidity rates have remained largely unchanged over the past 15 years.
Purpose of the Study:
- To review clinical syndromes, diagnostic methods, epidemiology, immunity, and treatment of Haemophilus influenzae type b infections.
- To highlight the ongoing challenge of disease prevention, including strategies for primary and secondary prevention.
- To discuss current and future developments in Haemophilus influenzae type b vaccines.
Main Methods:
- This review synthesizes information on clinical presentations, diagnostic approaches, and epidemiological trends of H. influenzae type b.
- It examines current treatment modalities and their impact on patient outcomes.
- The review also explores strategies for secondary prevention through antimicrobial prophylaxis and discusses advancements in vaccine development.
Main Results:
- Haemophilus influenzae type b infections present with diverse clinical syndromes such as meningitis, arthritis, pneumonia, and epiglottitis.
- Current antibiotic treatments have not led to significant reductions in mortality and morbidity over the last 15 years.
- Effective vaccines are available for infants 18 months and older, indicating the potential for primary prevention.
Conclusions:
- Prevention of invasive Haemophilus influenzae type b infections remains a critical medical challenge.
- Strategies for secondary prevention, including antimicrobial prophylaxis for high-risk groups, are important.
- The development of novel vaccine strategies is essential for the primary prevention of these severe childhood infections and future disease control.
Abstract:
Invasive Haemophilus influenzae type b infections are a major cause of severe infections in children between 2 months and 5 years of age. Meningitis, arthritis, pneumonia, cellulitis, osteomyelitis, and epiglottitis affect approximately 25,000 patients annually and are a major cause of mortality and morbidity in children. H. influenzae type b clinical syndromes, diagnostic methods, epidemiology, immunity, and treatment are discussed in this review. Although potent antibiotics have long been available for treatment, mortality and morbidity rates have not declined substantially in the last 15 years. Prevention of disease is therefore a continuous medical challenge. Secondary cases can be prevented by identification of the high-risk groups and the application of appropriate techniques, including antimicrobial prophylaxis. Primary prevention is the major goal of current research. H. influenzae type b vaccines currently are available for protection of infants 18 months of age and older. Prevention of primary and secondary disease and future developments, including new vaccine strategies, are stressed.